申请人:Oryzon Genomics S.A.
公开号:US20180079709A1
公开(公告)日:2018-03-22
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.